Live News EQUITY FLASH M impact Nov 16, 2026, 03:07 PM UTC Wegovy Cuts BMI 13.5% in Children in Phase 3 Trial Novo Nordisk said Wegovy cut BMI 13.5% in children aged 6 to under 12 in a Phase 3 trial. WEGOVY SquawkNews Desk